Cart
sales@molnova.com
BMS-707035
CAS No. 729607-74-3
BMS-707035( BMS 707035 | BMS707035 )
Catalog No. M15791 CAS No. 729607-74-3
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 31 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 177 | In Stock |
|
| 50MG | 324 | In Stock |
|
| 100MG | 528 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMS-707035
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.
-
DescriptionBMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.HIV Infection Phase 2 Discontinued.
-
In VitroBMS-707035 has antiviral activity with EC50 values of 2 nM and 17 nM in the presence of 10% FBS and 15 mg/mL human serum albumin, respectively.BMS-707035 has high plasma protein binding and not overtly cytotoxicy to several cell lines, with CC50 value of ≥45 μM.BMS-707035 has a relatively weak CYP inhibiton with IC50 value of ≥40 μM.
-
In VivoBMS-707035 has a low clearance effect in the rat, dog and monkey with moderate to long elimination half-lives in all species.Pharmacokinetic Parameters of BMS-707035 in rat, dog and monkey (IV).
-
SynonymsBMS 707035 | BMS707035
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-Iintegrase
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number729607-74-3
-
Formula Weight410.42
-
Molecular FormulaC17H19FN4O5S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCn1c(=O)c(c(nc1N2CCCCS2(=O)=O)C(=O)NCc3ccc(cc3)F)O
-
Chemical Name4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin-2-yl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dicker IB, et al. J Biol Chem. 2007 Oct 26;282(43):31186-96.
2. Langley DR, et al. Biochemistry. 2008 Dec 23;47(51):13481-8.
3. Al-Mawsawi LQ, et al. Expert Opin Emerg Drugs. 2008 Jun;13(2):213-25.
molnova catalog
related products
-
YLC2-155
YLC2-155 is a novel potent HIV-1 reverse transcriptase (RT) inhibitor that inhibits both polymerase (IC50=2.6 uM) and RNase H function (IC50=0.65 uM) of RT.
-
Tipranavir
Tipranavir is a protease inhibitor that inhibits HIV-1 resistant to more than 1 protease inhibitor .
-
Raltegravir potassiu...
A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
